NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

Biotechnology

NewLimit

NewLimit's headquarters in South San Francisco, CA, United States

Brian Armstrong

Jacob Kimmel

Alex Kim

Burak Dura

Group Leader, Immunology

Head Of Computational Sciences

Operations Specialist

Scientist, Lipid Nano Particle Delivery

Scientist/senior Scientist, Immunology

Description

People (8)

Burak Dura

David Reynolds

Nicholas Bernstein

Wesley McKeithan

Jenny Ng

Blake Byers

Jacob Kimmel

Ryan Theisen

Jobs (6)

Group Leader, Immunology

Head Of Computational Sciences

Operations Specialist

Scientist, Lipid Nano Particle Delivery

Operations Specialist

Scientist/senior Scientist, Immunology